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mM Hepes (pH 7.4). The standard internal (pipette) solution contained 140 mM CsC 2 H 3 O 2 , 3.5 mM CaCl 2 , 3.72 mM MgCl 2 , 10 mM EGTA, and 10mM Hepes (pH7.2). The calculated free Ca 2+ concentration was 100 nM. For activation of store-operated CRAC channels, this internal solution was changed to 140 mM CsC 2 H 3 O 2 , 4.17 mM MgCl 2 , 10 mM EGTA, and 10 mM Hepes (pH 7.2) plus 2 µM adenophostin A. For experiments with the RBL-cells, the standard extracellular saline contained 120 mM NaCl, 2.8 mM KCl, 10 mM CsCl, 2 mM MgCl 2 , 10 mM CaCl 2 , 10 mM glucose, 10 mM Hepes (pH 7.4), and the standard internal (pipette) solution contained 120 mM Cs-glutamate, 8 mM NaCl, 3 mM MgCl 2 ,10 mM Cs-BAPTA, 10 mM Hepes (pH7.2) plus 2 µM adenophostin A.
Constructs. cDNA encoding human STIM1 was obtained from Dharmacon Inc., (Chicago, IL, USA), and modified to render it siRNA-resistant as described. To generate the Lck-STIM1-C construct, two oligonucleotides (sense and antisense) were generated to prepare an insert coding for the plasma membrane targeting sequence of the Lck kinase (MGCGCSSHPE) followed by a hydrophobic linker (TKLTEER) which included an EcoR1 site at the beginning and an Acl1 site at the end, in-frame with the STIM1 C-terminal region. Following phosphorylation and annealing of these sequences, the insert was ligated to the STIM1 C-terminus position 251-685 (cloned out using PCR including an Acl1 site at the beginning and a Xho1 site following the stop codon) and inserted into a pcDNA3.1 + backbone (Invitrogen). For experiments requiring an Cterminally eGFP-tagged version (Lck-STIM1-C-eGFP), a phosphorylated and annealed linker (AflII to BamH1) was used to remove the stop codon from the above construct, and to allow subcloning into a pEGFP-n3 backbone (Invitrogen) in frame with the eGFP.
STIM1-CT constructs were generated by first removing the Lck domain from either the Lck-STIM1-C or Lck-STIM1-C-eGFP construct, as appropriate, using primers designed to introduce a Kpn1 site and a methionine start codon immediately prior to position 251 and the Pml1 site within the C-terminus. The Kpn1/Pml1 cut PCR product was then ligated to a Kpn1/Pml1 cut Lck-STIM1-C backbone.
The S-to-A mutant Lck-STIM1-C constructs were prepared by designing five oligonucleotides (2 sense and 3 antisense) corresponding to the SacII to Acl1 sites in the Lck-STIM1-C construct modified by changing the residue at position 6 in the Lck domain from a serine to an alanine. The oligonucleotides were phosphorylated, annealed and ligated to the Lck-STIM1-C SacII to Acl1 cut backbone.
For the N-terminally eGFP-tagged STIM1-C-CAAX construct, oligonucleotides were designed to add a CAAX box domain to the STIM1 C-terminus including a AflII site at the 5' end and a BamH1 site at the 3' end. These were phosphorylated, annealed and ligated, along with a Kpn1 to AflII STIM1-CT fragment, to a Kpn1/BamH1 cut pAcGFP1-C1 backbone.
All constructs were confirmed by sequencing of the protein coding regions. 
